Keywords: Japan, Drug pricing, Generics, Long-listed drugs, P Reed Maurer

Japan's dilemma: Generics vs long-listed brands, by P Reed Maurer

Article | 30 October 2012

In most countries, promoting generics to save money in the health care budget is considered good policy. There is no ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in